Monoclonal Gammopathy Presenting Section as Peripheral Neuropathy

Monoclonal Gammopathy Presenting Section as Peripheral Neuropathy

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a disorder of peripheral nervous system, which presents with a long duration (eight weeks) of sensory and/or motor, symmetric/asymmetric symptoms. Aetiology ranges from infections, inflammations, autoimmune disorders, to vasculitis and ma...

Full description

Bibliographic Details
Main Authors:	Vishaka Agarwal, Koukutla Soundarya Rajeshwari, KT Jayakumar, Satish, Chetan Somu
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2021-04-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	chronic inflammatory demyelinating polyradiculoneuropathy electrodiagnosis plasma cell dyscrasia
Online Access:	https://www.jcdr.net/articles/PDF/14800/47090_CE[Ra1]_F[SK]_PF1(AG_KM)_PFA(SL)_PB(AG_KM)_PN(KM).pdf

Similar Items

Diagnostic Value of Sensory Nerve Conduction Studies in Acute Inflammatory Demyelinating Polyradiculoneuropathy
by: Safiye Gül Kenar, et al.
Published: (2023-12-01)

Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report
by: Emily A. Eton, et al.
Published: (2020-04-01)

Electrophysiological assessment of Chronic Inflammatory Demyelinating Peripheral Polyradiculoneuropathy(CIDP) in Patients with Diabetes Mellitus
by: Marwa S. Suhail, et al.
Published: (2014-10-01)

Chronic inflammatory demyelinating polyradiculoneuropathy overdiagnosis in Russia
by: Daria A. Grishina, et al.
Published: (2023-09-01)

Processing speed impairment in chronic inflammatory demyelinating polyneuropathy patients: a cross-sectional study
by: Iara Senem, et al.
Published: (2022-10-01)

Clinical heterogeneity of anti⁃neurofascin 155 antibody positive paranodopathy
by: CHEN Hai, et al.
Published: (2022-04-01)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)

Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
by: J. Bradley Layton, et al.
Published: (2023-05-01)

COVID-19 Associated Guillain-Barré Syndrome- A Case Series
by: Pankaj Kumar Saini, et al.
Published: (2022-04-01)

Chronic Inflammatory Polyradiculoneuropathy
by: J Gordon Millichap
Published: (1997-12-01)

Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis
by: Athena Michaelides, et al.
Published: (2019-06-01)

Recurrent Guillain-Barre Syndrome- A Case Report
by: Dilesha WL, et al.
Published: (2015-05-01)

High salt diet ameliorates functional, electrophysiological and histological characteristics of murine spontaneous autoimmune polyneuropathy
by: Petra Huehnchen, et al.
Published: (2019-04-01)

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis
by: Laurent Kremer, et al.
Published: (2019-03-01)

Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones
by: Maho Terashita, et al.
Published: (2023-12-01)

Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study
by: Hedda Luise Verhasselt, et al.
Published: (2023-05-01)

Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review
by: Szymon Andrusiów, et al.
Published: (2023-08-01)

Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications
by: Edyta Dziadkowiak, et al.
Published: (2023-05-01)

Incidencia y características clínicas del síndrome de Guillain-Barré en la comarca de Osona (Barcelona, España) (2003-2016)
by: J.M. Aragonès, et al.
Published: (2021-09-01)

Case Report: Chronic inflammatory demyelinating polyradiculoneuropathy rather than hemophagocytic lymphohistiocytosis—the initial phenotype of PRF1 gene mutation
by: Lin-Yan Hu, et al.
Published: (2023-12-01)

High-dose immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis
by: Satomi Hiya, et al.
Published: (2022-06-01)

Case of Chronic Inflamatory Demyelinating Polyneuropathy: A Reminder
by: Suzan Şaylısoy, et al.
Published: (2011-03-01)

Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-05-01)

Hereditary Neuropathy with liability to Pressure Palsies revealed by a Chronic Inflammatory Demyelinating Polyradiculoneuropathy. A case report and literature review
by: Djamila Mahmoudi, et al.
Published: (2022-04-01)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
by: Jean-Michel Vallat, et al.
Published: (2022-04-01)

Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review
by: Edward J. Filippone, et al.
Published: (2021-11-01)

Demyelinating Polyradiculoneuropathy in Chronic Lymphocytic Leukemia: A Case Report on BTKis versus Venetoclax-Rituximab
by: Alessandro Cellini, et al.
Published: (2023-12-01)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
by: Colin Anderson-Smits, et al.
Published: (2023-05-01)

Red Flags for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Sarcoidosis or Connective Tissue Diseases
by: Clément Vialatte de Pémille, et al.
Published: (2023-05-01)

Chronic inflammatory demyelinating polyneurophaty: assessment of the cognitive function and quality of life
by: Larissa Kozow, et al.
Published: (2022-12-01)

Autoantibodies in central nervous system and neuromuscular autoimmune disorders: A narrative review
by: Mi Young Jeon, et al.
Published: (2022-06-01)

The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy
by: Kathleen M. Hagen, et al.
Published: (2021-03-01)

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
by: S. R. M. Bus, et al.
Published: (2021-02-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Multiple Sites Ultrasonography of Peripheral Nerves in Differentiating Charcot–Marie–Tooth Type 1A from Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Jingwen Niu, et al.
Published: (2017-05-01)

April 2015 pulmonary case of the month: get down
by: Pham M, et al.
Published: (2015-04-01)

Crystalline deposits in the cornea and various areas of the kidney as symptoms of an underlying monoclonal gammopathy: a case report
by: C. Lindemann, et al.
Published: (2021-04-01)

Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management
by: Camille Cohen, et al.
Published: (2021-03-01)

Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders
by: Edyta Dziadkowiak, et al.
Published: (2022-11-01)

Beneficial effects and safety of traditional Chinese medicine for chronic inflammatory demyelinating polyradiculoneuropathy: A case report and literature review
by: Yao Xie, et al.
Published: (2023-04-01)